Literature DB >> 17935121

DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.

L Boldrup1, P J Coates, X Gu, K Nylander.   

Abstract

The human p63 gene codes for multiple protein isoforms and is commonly over-expressed in squamous cell carcinoma of head and neck (SCCHN). This expression is predominantly of the DeltaN- and beta-isoforms, the former lacking the p53-related transactivation domain. p63 can activate or repress transcription of p53 and p73 target genes, but also has unique transcriptional targets and, unlike other p53 family members, is required for normal development and differentiation of squamous epithelia. We have identified novel targets of p63, using microarray analysis of SCCHN cells that stably over-express individual DeltaNp63 isoforms. All three isoforms induced expression of the cancer stem cell marker, CD44, with the DeltaNp63beta isoform showing strongest induction. Using chromatin immunoprecipitation, we were unable to show direct binding of p63 to the CD44 promoter, but found that p63 specifically increased expression of CD44 lacking variant exon 2. Each of the DeltaNp63 isoforms up-regulated expression of keratins 6A and 14 and down-regulated expression of keratins 4 and 19, in keeping with their expression patterns in SCCHN. The data strengthen the idea that p63 has key roles in regulating normal and abnormal differentiation processes through both induction and repression of genes with opposite functions. The identification of up-regulation and differential splicing of CD44 following p63 over-expression indicates roles in the regulation of adhesion, metastasis and the cancer stem cell phenotype. (c) 2007 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935121     DOI: 10.1002/path.2237

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.

Authors:  Maren Cam; Manish Charan; Alessandra M Welker; Piyush Dravid; Adam W Studebaker; Jeffrey R Leonard; Christopher R Pierson; Ichiro Nakano; Christine E Beattie; Eugene I Hwang; Madhuri Kambhampati; Javad Nazarian; Jonathan L Finlay; Hakan Cam
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

2.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

3.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

4.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 5.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

Review 7.  Epidermal stem cells in skin homeostasis and cutaneous carcinomas.

Authors:  S Aznar Benitah
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

Review 8.  Current aspects of targeted therapy in head and neck tumors.

Authors:  Andreas Dietz; Andreas Boehm; Christian Mozet; Gunnar Wichmann; Athanassios Giannis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07       Impact factor: 2.503

9.  The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins.

Authors:  S Wolff; F Talos; G Palacios; U Beyer; M Dobbelstein; U M Moll
Journal:  Cell Death Differ       Date:  2009-03-20       Impact factor: 15.828

10.  Identification and functional characterization of two new transcriptional variants of the human p63 gene.

Authors:  Marina Mangiulli; Alessio Valletti; Mariano Francesco Caratozzolo; Apollonia Tullo; Elisabetta Sbisà; Graziano Pesole; Anna Maria D'Erchia
Journal:  Nucleic Acids Res       Date:  2009-08-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.